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Editorial
CIRCI – What should the clinician do?
The activation of hypothalamic pituitary-adrenal (HPA) axis is an integral part of body’s adaptive response to stress and critical illnesses. It is well-known 
that in catecholamine refractory shock replacement with 
corticosteroids is one of the standard lines of management 
and helps in correction of shock as well as optimization and 
improved response to vasoactive drugs [1]. Though adrenal 
failure may be encountered in critically ill patients who may 
not be shock; its clinical relevance and therapeutic importance 
is controversial. The authors of the study “Critical illness 
related corticosteroid insufficiency (CIRCI) in children - A 
single center, prospective, cohort study” published in this issue 
of IJCH have made a good effort to find out CIRCI incidence 
in pediatric patients [2].
The authors found that about 38% patients had CIRCI and 
concluded that the CIRCI was not an independent risk factor for 
mortality; however, this is in contrast to certain adult studies [3]. 
This brings us to the point of, what should be the clinical 
relevance of this; and whether these patients if not in shock, 
would benefit or not from corticosteroid supplementation. 
Additional information or further studies should probe into 
this matter. CIRCI was highest among patients with septic 
shock and is not a surprising observation. There was also an 
unusually high mortality in septic shock subgroup. We do not 
know whether they all received an early goal directed therapy 
and how many of them received corticosteroids. A sub-group 
analysis for shock and non-shock patients separately; would 
have been highlighted the impact of CIRCI on non-shock 
patients more clearly.
The authors also concluded that there was a significantly 
higher requirement of vasoactive drugs and fluid boluses 
in the CIRCI group. We would disagree with them based on 
the following factors. First, they have considered only the 
fluids given after PICU admission and most of these patients 
would have been resuscitated in the emergency room. Hence, 
the actual amount of boluses that was given is different from 
what is quoted. Second, there was no fixed protocol for giving 
vasoactive drugs. Hence, directly concluding that CIRCI 
leads to higher requirement of these agents would be little 
redundant. Based on available literature, we would agree that 
CIRCI patients require higher support and are more likely to 
have catecholamine refractory shock; but a refractory shock is 
a different entity and “higher number” of vasoactive drugs is 
different. We also do not know whether these drugs were used 
in maximal doses or not. Mean doses of individual vasoactive 
drugs would have added more meaning to the results but could 
not be done due to logistic reasons. A very interesting and 
relevant fact that has been observed by the authors is the higher 
levels of baseline cortisol in patients with CIRCI as compared 
to controls. Other studies have also shown this and in fact, the 
mortality is shown to be higher in these patients [4].
This is a wonderful study and has added relevant 
information on CIRCI in the Indian context. Researchers 
in critical care should take this forward, and we should try 
and find out the therapeutic implications of this. Only septic 
shock and early acute respiratory distress syndrome have been 
proven to benefit from corticosteroid supplementation. We do 
not have any evidence in other disease conditions at present, 
and screening for such patients would be worthwhile only if a 
therapeutic benefit can be established. Hence, another research 
question would be the selection of the patients, i.e. all critically 
ill patients should be screened or should we have some criteria 
to identify at risk patients?
There are limitations to diagnosis of CIRCI that need to be 
also thought of. Free cortisol levels (rather than total cortisol 
levels) have more clinical significance, but due to technical 
difficulties are not done routinely. Adrenocorticotropic 
hormone (ACTH) stimulation test also has its disadvantages. It 
is poorly reproducible and does not truly reflect the endogenous 
integrity of the HPA axis. The delta cortisol values proposed in 
guidelines also need to be critically reviewed because they are 
highly dependent on basal cortisol levels. The same has been 
observed in this study. Low dose of 1 mcg ACTH may be more 
physiologic and relevant [5]; but is still not recommended. 
In addition to these limitations, we do not know whether 
a laboratory deficiency of cortisol truly reflects a cellular 
deficiency and vice versa [6]. We still need to ponder the big 
question – “What should the clinician do?”
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